Kentucky Urged to Boost HIV Prevention with Daily PrEP Pill as CDC Highlights Effectiveness

Why it matters locally: The CDC's renewed emphasis on daily PrEP pills as an HIV prevention method directly impacts Kentucky due to the state's vulnerability to HIV transmission. While specific statistics are needed to fully determine the extent of the problem in Kentucky, this national initiative is relevant to the state and should be considered to improve the health of Kentuckians. Improving access to and awareness of PreP is a vital step towards reducing the impact of the virus in the state.

---

Atlanta, GA – The Centers for Disease Control and Prevention (CDC) is focusing attention on the role of daily oral pre-exposure prophylaxis (PrEP) as a method for preventing HIV transmission. Information released by the agency underscores the potential impact of PrEP when taken as prescribed. PrEP involves taking a daily pill, which contains anti-HIV medications, to significantly reduce the risk of HIV infection. The CDC emphasizes that its effectiveness hinges on consistent and correct usage. The CDC's information indicates a persistent gap between the number of individuals who could benefit from PrEP and the number who are currently prescribed it. This disparity highlights a need for increased awareness among both at-risk populations and healthcare providers. Expanding education efforts and access to PrEP could contribute to reducing new HIV infections, according to the agency. The CDC recommends discussing PrEP with a healthcare provider to determine if it is appropriate for individuals at risk for HIV. Further information, including guidelines for prescribing PrEP and resources for finding local providers, can be found on the CDC’s website.